Using the Taiwan Biobank, we aimed to identify traits and genetic variations that could predispose Han Chinese women to primary dysmenorrhea. Cases of primary dysmenorrhea included those who self-reported “frequent dysmenorrhea” in a dysmenorrhea-related Taiwan Biobank questionnaire, and those who have been diagnosed with severe dysmenorrhea by a physician. Controls were those without self-reported dysmenorrhea. Customized Axiom-Taiwan Biobank Array Plates were used to perform whole-genome genotyping, PLINK was used to perform association tests, and HaploReg was used to conduct functional annotations of SNPs and bioinformatic analyses. The GWAS analysis included 1186 cases and 24,020 controls. We identified 53 SNPs that achieved genome-wide significance (P < 5 × 10−8, which clustered in 2 regions. The first SNP cluster was on chromosome 1, and included 24 high LD (R2 > 0.88) variants around the NGF gene (lowest P value of 3.83 × 10−13 for rs2982742). Most SNPs occurred within NGF introns, and were predicted to alter regulatory binding motifs. The second SNP cluster was on chromosome 2, including 7 high LD (R2 > 0.94) variants around the IL1A and IL1B loci (lowest P value of 7.43 × 10−10 for rs11676014) and 22 SNPs that did not reach significance after conditional analysis. Most of these SNPs resided within IL1A and IL1B introns, while 2 SNPs may be in the promoter histone marks or promoter flanking regions of IL1B. To conclude, data from this study suggest that NGF, IL1A, and IL1B may be involved in the pathogenesis of primary dysmenorrhea in the Han Chinese in Taiwan.
This is a preview of subscription content, access via your institution
Subscribe to Journal
Get full journal access for 1 year
only $9.92 per issue
All prices are NET prices.
VAT will be added later in the checkout.
Tax calculation will be finalised during checkout.
Get time limited or full article access on ReadCube.
All prices are NET prices.
The datasets used and analyzed during the current study are available from the corresponding author on reasonable request. Correspondence and requests for materials should be addressed to Chien-Chang Lee (email@example.com).
Weissman AM, Hartz AJ, Hansen MD, Johnson SR. The natural history of primary dysmenorrhoea: a longitudinal study. BJOG 2004;111:345–52.
Wong LP, Khoo EM. Dysmenorrhea in a multiethnic population of adolescent Asian girls. Int J Gynecol Obstet. 2010;108:139–42.
Dawood MY. Nonsteroidal anti-inflammatory drugs and changing attitudes toward dysmenorrhea. Am J Med. 1988;84:23–9.
Akiyama S, Tanaka E, Cristeau O, Onishi Y, Osuga Y. Evaluation of the treatment patterns and economic burden of dysmenorrhea in Japanese women, using a claims database. Clinicoecon Outcomes Res. 2017;9:295–306.
Proctor M, Farquhar C. Diagnosis and management of dysmenorrhoea. BMJ 2006;332:1134–8.
Coco AS. Primary dysmenorrhea. Am Fam Physician. 1999;60:489–96.
French L. Dysmenorrhea in adolescents: diagnosis and treatment. Paediatr Drugs. 2008;10:1–7.
Latthe P, Latthe M, Say L, Gülmezoglu M, Khan KS. WHO systematic review of prevalence of chronic pelvic pain: a neglected reproductive health morbidity. BMC Public Health. 2006;6:177.
Ju H, Jones M, Mishra G. The prevalence and risk factors of dysmenorrhea. Epidemiol Rev. 2014;36:104–13.
Jamieson DJ, Steege JF. The prevalence of dysmenorrhea, dyspareunia, pelvic pain, and irritable bowel syndrome in primary care practices. Obstet Gynecol. 1996;87:55–8.
Reddish S. Dysmenorrhoea. Aust Fam Physician. 2006;35:842–4.
Osayande AS, Mehulic S. Diagnosis and Initial Management of Dysmenorrhea. AFP 2014;89:341–6.
Jensen DV, Andersen KB, Wagner G. Prostaglandins in the menstrual cycle of women. A review. Dan Med Bull. 1987;34:178–82.
Willman EA, Collins WP, Clayton SG. Studies in the involvement of prostaglandins in uterine symptomatology and pathology. Br J Obstet Gynaecol. 1976;83:337–41.
Rees MCP, Marzo VD, Tippins JR, Morris HR, Turnbull AC. Leukotriene release by endometrium and myometrium throughout the menstrual cycle in dysmenorrhoea and menorrhagia. J Endocrinol. 1987;113:291–5.
Akerlund M, Strömberg P, Forsling ML. Primary dysmenorrhoea and vasopressin. Br J Obstet Gynaecol. 1979;86:484–7.
Durain D. Primary dysmenorrhea: assessment and management update. J Midwifery Women’s Health. 2004;49:520–8.
Sundell G, Milsom I, Andersch B. Factors influencing the prevalence and severity of dysmenorrhoea in young women. BJOG. 1990;97:588–94.
Harlow SD, Park M. A longitudinal study of risk factors for the occurrence, duration and severity of menstrual cramps in a cohort of college women. BJOG. 1996;103:1134–42.
Latthe P, Mignini L, Gray R, Hills R, Khan K. Factors predisposing women to chronic pelvic pain: systematic review. BMJ 2006;332:749–55.
Silberg JL, Martin NG, Heath AC. Genetic and environmental factors in primary dysmenorrhea and its relationship to anxiety, depression, and neuroticism. Behav Genet. 1987;17:363–83.
Jones AV, Hockley JRF, Hyde C, Gorman D, Sredic-Rhodes A, Bilsland J, et al. Genome-wide association analysis of pain severity in dysmenorrhea identifies association at chromosome 1p13.2, near the nerve growth factor locus. Pain 2016;157:2571–81.
McMahon SB. NGF as a mediator of inflammatory pain. Philos Trans R Soc Lond B Biol Sci. 1996;351:431–40.
Li Z, Chen J, Zhao Y, Wang Y, Xu J, Ji J, et al. Common variants in ZMIZ1 and near NGF confer risk for primary dysmenorrhoea. Nat Commun. 2017;8:1–7.
Hirata T, Koga K, Johnson TA, Morino R, Nakazono K, Kamitsuji S, et al. Japanese GWAS identifies variants for bust-size, dysmenorrhea, and menstrual fever that are eQTLs for relevant protein-coding or long non-coding RNAs. Sci Rep. 2018;8:1–17.
Chen C-H, Yang J-H, Chiang CWK, Hsiung C-N, Wu P-E, Chang L-C, et al. Population structure of Han Chinese in the modern Taiwanese population based on 10,000 participants in the Taiwan Biobank project. Hum Mol Genet. 2016;25:5321–31.
Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MAR, Bender D, et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet. 2007;81:559–75.
Pruim RJ, Welch RP, Sanna S, Teslovich TM, Chines PS, Gliedt TP, et al. LocusZoom: regional visualization of genome-wide association scan results. Bioinformatics. 2010;26:2336–7.
Ward LD, Kellis M. HaploReg: a resource for exploring chromatin states, conservation, and regulatory motif alterations within sets of genetically linked variants. Nucleic Acids Res. 2012;40:D930–934.
Watanabe K, Taskesen E, van Bochoven A, Posthuma D. Functional mapping and annotation of genetic associations with FUMA. Nat Commun. 2017;8:1826.
Pezet S, McMahon SB. Neurotrophins: mediators and modulators of pain. Annu Rev Neurosci. 2006;29:507–38.
McKelvey L, Shorten GD, O’Keeffe GW. Nerve growth factor-mediated regulation of pain signalling and proposed new intervention strategies in clinical pain management. J Neurochem. 2013;124:276–89.
Brown MT, Murphy FT, Radin DM, Davignon I, Smith MD, West CR. Tanezumab reduces osteoarthritic hip pain: results of a randomized, double-blind, placebo-controlled phase III trial. Arthritis Rheum. 2013;65:1795–803.
Lane NE, Schnitzer TJ, Birbara CA, Mokhtarani M, Shelton DL, Smith MD, et al. Tanezumab for the Treatment of Pain from Osteoarthritis of the Knee. N. Engl J Med. 2010;363:1521–31.
Jayabalan P, Schnitzer TJ. Tanezumab in the treatment of chronic musculoskeletal conditions. Expert Opin Biol Ther. 2017;17:245–54.
Hertelendy F, Rastogi P, Molnár M, Romero R. Interleukin-1beta-induced prostaglandin E2 production in human myometrial cells: role of a pertussis toxin-sensitive component. Am J Reprod Immunol. 2001;45:142–7.
Korita D, Itoh H, Sagawa N, Yura S, Yoshida M, Kakui K, et al. Cyclic mechanical stretching and interleukin-1alpha synergistically up-regulate prostacyclin secretion in cultured human uterine myometrial cells. Gynecol Endocrinol. 2004;18:130–7.
Sooranna SR, Grigsby PL, Engineer N, Liang Z, Sun K, Myatt L, et al. Myometrial prostaglandin E2 synthetic enzyme mRNA expression: spatial and temporal variations with pregnancy and labour. Mol Hum Reprod. 2006;12:625–31.
We thank the staff of the Core Labs, the Department of Medical Research, and National Taiwan University Hospital for technical support.
This study was funded by the Taiwan National Science Foundation Grant NSC 102-2314-B-002 −131 -MY3; National Taiwan University Hospital Grant NTUH.106-P04; Taiwan National Ministry of Science and Technology Grants MOST 104-2314-B-002 −039 -MY3, and MOST 106-2811-B-002-048. No funding bodies had any role in study design, data collection, and analysis, decision to publish, or preparation of the manuscript.
The authors declare no competing interests.
Ethics approval and consent to participate
This research project was approved by the ethics committee of the National Taiwan University Hospital Institutional Review Board and Institutional Review Board of Taiwan Biobank (TWBR10602-05). This database study was performed on de-identified subjects and informed consent was not required.
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Lee, CC., Lee, Mt.G., Huang, IH. et al. Genome-wide association study of primary dysmenorrhea in the Taiwan Biobank validates associations near the NGF and IL1 gene loci. J Hum Genet 67, 449–458 (2022). https://doi.org/10.1038/s10038-022-01023-2